Question Title

* 1. How many years have you been in practice?

Question Title

* 2. How many patients with MM do you treat each week?

Question Title

* 3. Please select the option that best describes your practice:

Question Title

* 4. Of the patients you will see in the next week, about how many will benefit from the information you learned today?

Question Title

* 5. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 7. After participating in this activity, I am now able to:

  Strongly agree Agree Neutral Disagree Strongly disagree
Differentiate between the proteasome inhibitors (PIs), outlining the efficacy and safety profiles, advantages and disadvantages, and quality of life impact of each
Select tailored treatment combinations for a cytogenetically high-risk multiple myeloma (MM) patient at first and second relapse
Expound the rationale for PI-based treatment combinations for patients with relapsed/refractory MM

Question Title

* 8. The content presented:

  Strongly agree Agree Neutral Disagree Strongly disagree
Enhanced my current knowledge base
Addressed my most pressing questions
Promoted improvements or quality in health care
Was scientifically rigorous and evidence based

Question Title

* 9. This activity was free from commercial bias.

Question Title

* 10. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 13. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

T